Navigation Links
Childhood epilepsy research offers new hope for seizure control
Date:10/22/2007

Scientists still do not know what causes epileptic seizures, but researchers from Melbournes Howard Florey Institute are one step closer to solving this puzzle with the help of their newly developed genetically modified epileptic mouse.

This is the first human genetic mutation based mouse model in the world that mimics childhood absence epilepsy (CAE). The mouse is now helping Dr Steven Petrou and his team to understand the genesis of epilepsy, which will aid in the development of better anti-seizure drugs.

CAE involves brief staring spells, during which the child is not aware or responsive. These episodes can occur one to 50 times per day and the age of onset is usually three to 10 years.

In about 30% of people, anti-epileptic drugs do not adequately control their seizures and many drugs have side-effects such as rashes, lethargy and memory problems.

Dr Petrou said new treatment strategies were urgently needed to create beneficial drugs without side-effects.

The problem with current drugs is that they treat the symptoms, not the root cause, Dr Petrou said.

To develop new treatment strategies we need to understand the genesis of epilepsy, and this mouse model should provide a window into that fundamental process.

We all know seizures occur if the brains cortex goes haywire, but something is happening prior to that event to cause neurons to misfire, and we want to understand that initial event.

Because mice grow so quickly, changes in the brain can be readily seen and measured.

In a week the mouse can go from no seizures to seizures, so we can investigate what changes are occurring in that period and what is happening in the critical time window that leads to seizures.

Initial findings suggest there is a defect in the brains cortex which may be related to the beginning of seizures in CAE but we are delving into deeper brain structures as well, Dr Petrou said.

The inherited human gene mutation that causes CAE was first detected by Dr Petrous collaborator, Prof Samuel Berkovic from Austin Health. Through genetic manipulation, Dr Petrou has introduced this human mutation into the mouse DNA, allowing the researchers to study a mouse version of the human condition.

The mutation itself is rare in humans but it causes CAE, which is one of the more common forms of epilepsy.

Dr Petrou said that modelling genetic epilepsies in mice will allow researchers to understand epilepsy from the molecular level all the way through to physical behaviour.

Creating this link in the human brain is impossible due to the highly invasive methodology required, so mouse models provide us with a unique opportunity to discover mechanisms of seizure genesis, Dr Petrou added.


'/>"/>

Contact: Merrin Rafferty
merrin.rafferty@florey.edu.au
61-383-441-658
Research Australia
Source:Eurekalert

Related medicine news :

1. Focused Treatment For Childhood Cancer
2. Osteoporosis associated with Childhood Cancer
3. Stroke also in list of common childhood ailments
4. Asthma is not just a childhood condition
5. Asthma not just a childhood condition
6. Childhood Sunburn Can Lead to Skin Cancer Later
7. Preventing Childhood Deaths
8. Radiation Not Needed for Childhood Cancers
9. Troubled Childhood found to affect your Liver
10. Elevated LDL levels in Childhood could be Predictors of Heart Disease
11. Persistent Childhood Wheeze Probably Inherited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and which He does not. Yisrayl says with so many titles and names for ... but he says with a little Scripture, backed with a lot of research, the truth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is ... Côté has 20+ years of experience within the beauty industry, ranging from marketing, ... array of high-end cosmetic brands, retail brands and outlets in Canada and New ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/19/2017)... April 19, 2017 Cardiology devices segment is anticipated ... The Cardiology Devices segment is likely to create ... Mn in 2018 over 2017. By the end of 2027, ... close to US$ 700 Mn, expanding at a CAGR of ... the Asia Pacific reprocessed medical devices ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology: